'What Else Is Going to Change?': What ACIP's Hep B Guidance Means for the Future of Vaccines - MedCity News
Briefly

'What Else Is Going to Change?': What ACIP's Hep B Guidance Means for the Future of Vaccines - MedCity News
"Now, ACIP is proposing to roll-back guidance for hepatitis B that has been in effect for more than 30 years. Last week, ACIP voted 8-3 to recommend "individual-based decision-making for parents deciding whether to give the hepatitis B vaccine, including the birth dose, to infants born to women who test negative for the virus," according to a news release from the CDC. For those not receiving the birth dose, ACIP suggested receiving the initial dose "no earlier" than two months."
"Hepatitis B is a contagious virus that infects the liver and is a leading cause of liver cancer. It is transmitted through blood and bodily fluids. Since 1991, when the CDC recommended the vaccination for all newborns, infections in children and teens have fallen by 99%. This recommendation has led to an outcry from many in the medical industry, including organizations like the American Medical Association, the American Academy of Pediatrics and the National Foundation for Infectious Diseases."
Robert F. Kennedy Jr. was appointed HHS Secretary in February and removed all members of the Advisory Committee on Immunization Practices, replacing them with vaccine critics. In September ACIP stopped recommending the combined MMRV vaccine before age four. ACIP voted 8-3 to recommend individual decision-making for parents on hepatitis B vaccination for infants born to women who test negative and suggested delaying the initial dose until two months when the birth dose is not given. Hepatitis B infects the liver, can cause liver cancer, and since universal newborn vaccination began in 1991 infections among children and teens have fallen 99%.
Read at MedCity News
Unable to calculate read time
[
|
]